Rare Disease Day

Looking at the bigger picture this Rare Disease Day

Learn more

You might have noticed our website looks a little different…

This Rare Disease Day, our Ipsen homepage has a new look to show our dedication to patients with rare diseases.

There are over 300 million people worldwide affected by a rare disease, so rare isn’t as rare as you think.

Find out more about Ipsen in rare diseases here.

Ipsen group

What we do

Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology, neuroscience and rare diseases.

2018 Annual Report

2018 was a remarkable year for Ipsen. We remain focused on executing our internal and external innovation strategy to build a robust pipeline, ensure continued growth and optimize value for patients and shareholders.

Explore Our 2018 Digital Annual Report

Careers at Ipsen

Ipsen offers exciting opportunities that will challenge your abilities , expand your skills and reward your contribution in a positive atmosphere of personal and professional development.

Search Ipsen positions

Research & Development



Ipsen’s commitment to research & development is our bold promise to patients to launch at least one new drug or meaningful new indication every year.  We will secure our future by building a pipeline of innovative medicines.


Read more

Research & Development

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020